US Marijuana Policy: Updated Odds on Federal Rescheduling

By Patricia Miller

Apr 24, 2026

2 min read

The US government may ease marijuana restrictions, with rescheduling odds now at 42.6%. Traders adjust expectations for long-term outcomes.

The US government is signaling a potential shift in federal marijuana policy, with rescheduling odds for cannabis now at 42.6%. These odds have seen a significant decline from 62% just a day prior.

On December 31, the market reached a high of 66% odds, driven by an abrupt increase at 12:30 PM. However, it retracted afterward. In contrast, the odds for June 30 plummeted to 9.5% following a substantial drop from 36% to 20% within a short period. This indicates that traders are moving away from expecting immediate developments in the near-term pipeline.

What does this mean for investors? The current market reflects a notable 33-point gap between the June 30 and December 31 contracts. This suggests that traders anticipate any federal action regarding rescheduling to unfold over a longer timeline rather than anticipate swift changes. With 252 days remaining until the December resolution and 68 days until June, the market is indicating that bureaucratic processes will likely slow progress.

Investors should remain alert for key developments. In the past 24 hours, the total USDC volume stood at $96,741. Observations reveal that the June 30 market requires $1,526 to increase odds by 5 points, while the December market only requires $775 for the same effect. This indicates that the December contract is more susceptible to abrupt fluctuations. Look out for official announcements from the DEA or comments from notable figures like Terrance Cole or Pam Bondi, as these could trigger quick movements in market contracts.

Currently, a YES share for rescheduling by December 31 is traded at 43¢, with a potential payout of $1, representing a 2.33x return. Investors considering this bet need to be confident in substantial federal action occurring within the next 252 days.

Important Notice And Disclaimer

This article does not provide any financial advice and is not a recommendation to deal in any securities or product. Investments may fall in value and an investor may lose some or all of their investment. Past performance is not an indicator of future performance.